Advancing Research on Care and Outcome Measurement 3.0 (ARCOM-3) – LOI

Well-being, Health and Biomedical Discovery


Academic Unit: inquire with unit

Memorial Deadline: RIS review not required for Letter of Intent stage

External Deadline: Wednesday 20th, September 2023


Brain Canada is pleased to be partnering with Alzheimer’s Association (ALZ) to launch the Advancing Research on Care & Outcome Measurement 3.0 (ARCOM-3) funding program, an international and collaborative competition aimed at addressing significant gaps in care and outcome measurement, and providing an opportunity to advance research so that care providers can ensure that they are implementing evidence-based practices and achieving desired outcomes.

Areas of interest for this program include, but are not limited to, quality metrics, systems of care, translation of interventions, increasing diversity within research and clinical trials, risk reduction, development of novel methods of data collection or analysis, and novel measures to validate previously developed measures or evaluation of measures in diverse and underrepresented populations.

Through this partnership, Brain Canada will co-fund up to four Canadian-led teams. Each award is limited to USD $250,000 over a period of up to two years.

Click here to view the Request for Applications.

Deadline for receipt of Letters of Intent: 5:00 pm ET on September 20, 2023  

Deadline for receipt of Full Applications:  5:00 pm ET on November 29, 2023  

Funding Sources

Alzheimer Society
Brain Canada Foundation

This opportunity was posted by: RGCS

Last modified: August 14, 2023